PTCT•benzinga•
B of A Securities Upgrades PTC Therapeutics to Neutral, Raises Price Target to $55
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 11, 2025 by benzinga